Natco Pharma to incorporate subsidiary company in Indonesia

20 Apr 2023 Evaluate

Natco Pharma has received an approval from the Board of Directors to incorporate a Subsidiary Company in Indonesia with an investment up to an amount not exceeding $3 million, of which, initially the company will invest $1 million for a stake of 51% as capital contribution and balance will be invested by the company as and when the funds are required by the subsidiary Company.

The balance stake of 49% will be held by PT. Mitra Medis Exim (MME), that belongs to Mitra Jaya Group which is a 40 year old multi-diversified group, as the co-promoter of the proposed subsidiary Company. MME is in the business of distribution for active pharmaceutical ingredients and excipients for the end users in Indonesia.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

850.95 -32.55 (-3.68%)
30-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1830.20
Dr. Reddys Lab 1183.00
Cipla 1549.65
Lupin 2094.65
Zydus Lifesciences 887.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...